The Estia Health Ltd (ASX: EHE) share price is having another strong day and is up 1.3% to $3.10.
Today's gain now brings the leading aged care provider's year-to-date return to over 19%.
This means its shares are outperforming both the market and rivals Japara Healthcare Ltd (ASX: JHC) and Regis Healthcare Ltd (ASX: REG) by some distance this year.
The strong gain is largely the result of a big improvement in its operating performance in FY 2017.
After a disastrous FY 2016, Estia Health returned to form in the first-half of FY 2017.
First-half EBITDA came in at $43 million, up 32% on the prior corresponding period. Furthermore, management advised that it is on course to meet full-year EBITDA guidance of between $86 million and $90 million.
Estia Health suspended its dividend last year. Shareholders will no doubt hope that its improved performance will allow for its resumption in the near future.
